Sylvain Fisson

Publications

• ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis
  Ophthalmology. Jul, 2016  |   Pubmed ID: 26948307
• Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells
  Journal of Immunology (Baltimore, Md. : 1950). Mar, 2016  |   Pubmed ID: 26826251
• Mouse Models of Primary Central Nervous System Lymphomas: Tools for Basing Funding and Therapeutic Strategies
  Journal of Neuro-oncology. Jan, 2015  |   Pubmed ID: 25300908
• Immunization of Mice with Lentiviral Vectors Targeted to MHC Class II+ Cells is Due to Preferential Transduction of Dendritic Cells in Vivo
  PloS One. 2014  |   Pubmed ID: 25058148
• Herpesvirus Detection and Cytokine Levels (IL-10, IL-6, and IFN-γ) in Ocular Fluid from Tunisian Immunocompetent Patients with Uveitis
  Journal of Medical Virology. Dec, 2013  |   Pubmed ID: 23960020
• Preclinical Study of Ublituximab, a Glycoengineered Anti-human CD20 Antibody, in Murine Models of Primary Cerebral and Intraocular B-cell Lymphomas
  Investigative Ophthalmology & Visual Science. May, 2013  |   Pubmed ID: 23611989
• Lymphoma B-cell Responsiveness to CpG-DNA Depends on the Tumor Microenvironment
  Journal of Experimental & Clinical Cancer Research : CR. 2013  |   Pubmed ID: 23561041
• Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis Between Intraocular Lymphoma or Uveitis
  PloS One. 2013  |   Pubmed ID: 23405064
• Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models
  Frontiers in Immunology. 2012  |   Pubmed ID: 22566974
• Murine Models of B-cell Lymphomas: Promising Tools for Designing Cancer Therapies
  Advances in Hematology. 2012  |   Pubmed ID: 22400032
• Th17 Cells Are Involved in the Local Control of Tumor Progression in Primary Intraocular Lymphoma
  PloS One. 2011  |   Pubmed ID: 21949734
• The Immune Microenvironments of Lung and Intraocular Tumors
  Bulletin Du Cancer. Jun, 2011  |   Pubmed ID: 21616749
• Tumor Microenvironment is Multifaceted
  Cancer Metastasis Reviews. Mar, 2011  |   Pubmed ID: 21271351
• Immune Infiltration in Human Cancer: Prognostic Significance and Disease Control
  Current Topics in Microbiology and Immunology. 2011  |   Pubmed ID: 20512556
• The Future of Primary Intraocular Lymphoma (retinal Lymphoma)
  Ocular Immunology and Inflammation. Nov-Dec, 2009  |   Pubmed ID: 20001255
• Selective Expression of Inhibitory Fcgamma Receptor by Metastatic Melanoma Impairs Tumor Susceptibility to IgG-dependent Cellular Response
  International Journal of Cancer. Dec, 2008  |   Pubmed ID: 18798552
• Animal Models of Intraocular Lymphomas
  Ophthalmic Research. 2008  |   Pubmed ID: 18421241
• Expansion of CD4+CD25+ Regulatory T Cells by Intravenous Immunoglobulin: a Critical Factor in Controlling Experimental Autoimmune Encephalomyelitis
  Blood. Jan, 2008  |   Pubmed ID: 17932250
• Impaired Th1/tc1 Cytokine Production of Tumor-infiltrating Lymphocytes in a Model of Primary Intraocular B-cell Lymphoma
  Investigative Ophthalmology & Visual Science. Jul, 2007  |   Pubmed ID: 17591892
• Induction of Antigen-specific Tolerance by Intrathymic Injection of Lentiviral Vectors
  Blood. Nov, 2006  |   Pubmed ID: 16809618
• Regulatory T Cells Control Uveoretinitis Induced by Pathogenic Th1 Cells Reacting to a Specific Retinal Neoantigen
  Journal of Immunology (Baltimore, Md. : 1950). Jun, 2006  |   Pubmed ID: 16751360
• Therapeutic Potential of Self-antigen-specific CD4+ CD25+ Regulatory T Cells Selected in Vitro from a Polyclonal Repertoire
  European Journal of Immunology. Apr, 2006  |   Pubmed ID: 16525991
• Natural Regulatory T Cells Control the Development of Atherosclerosis in Mice
  Nature Medicine. Feb, 2006  |   Pubmed ID: 16462800
• Identification of New CNS-resident Macrophage Subpopulation Molecular Markers for the Discrimination with Murine Systemic Macrophages
  Journal of Neuroimmunology. Dec, 2005  |   Pubmed ID: 16169092
• Ex Vivo Selection of Recipient-type Alloantigen-specific CD4(+)CD25(+) Immunoregulatory T Cells for the Control of Graft-versus-host Disease After Allogeneic Hematopoietic Stem-cell Transplantation
  Transplantation. Jan, 2004  |   Pubmed ID: 14726768
• Recipient-type Specific CD4+CD25+ Regulatory T Cells Favor Immune Reconstitution and Control Graft-versus-host Disease While Maintaining Graft-versus-leukemia
  The Journal of Clinical Investigation. Dec, 2003  |   Pubmed ID: 14660744
• Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State
  The Journal of Experimental Medicine. Sep, 2003  |   Pubmed ID: 12939344